Roivant Sciences Ltd. (NASDAQ: ROIV)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| 29.91 (0.02 / 0.07%) | 30.01 (0.13 / 0.44%) | 30.24 (0.23 / 0.77%) |
| 29-May 09:15 | 29-May 16:00 | 29-May 17:20 |
Sector: Healthcare || Industry: Biotechnology
| Previous Close | 29.88 | Year Low | 10.71 |
| Open | 30.33 | Year High | 32.79 |
| Day Low | 29.65 | Price Avg 50 | 28.54 |
| Day High | 30.42 | Price Avg 200 | 22.23 |
| Volume | 6.86 M | Market Cap | 21.59 B |
News
| Symbol | Catalyst News |
|---|---|
| ROIV | Roivant Sciences Ltd. (ROIV) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript Seeking Alpha | 2026-05-29 17:24:06 Roivant Sciences Ltd. (ROIV) Q4 2025 Earnings Call Transcript Seeking Alpha | 2026-05-20 18:20:55 Roivant Sciences Q4 Earnings Call Highlights MarketBeat | 2026-05-20 10:08:42 Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates Zacks Investment Research | 2026-05-20 09:15:12 Roivant Sciences ($ROIV) Q4 Loss Widen; Revenue Miss Estimates Catalyst picR | 2026-05-20 07:45:51 Montes Archimedes Acquisition (ROIV) Upgraded to Buy: Here's Why Zacks Investment Research | 2026-05-19 13:01:16 Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 Transcript Seeking Alpha | 2026-05-13 16:50:45 |
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| ROIV | 0.44 | -2.41 | 9.05 | 3.70 | 44.21 | 165.58 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/20/2026 | BMO | ROIV | Roivant Sciences | Q4 2026 | EPS | -0.35 | -0.27 | 22.86 | -0.22 | -22.70 | |
| 05/20/2026 | BMO | ROIV | Roivant Sciences | Q4 2026 | REV | 3.82 M | 2.52 M | -34.03 | 7.57 M | -66.71 | |
| 02/06/2026 | BMO | ROIV | Roivant Sciences | Q3 2026 | EPS | -0.32 | -0.24 | 25.00 | -0.20 | -20.00 | |
| 02/06/2026 | BMO | ROIV | Roivant Sciences | Q3 2026 | REV | 6.47 M | 2.00 M | -69.12 | 9.02 M | -77.84 | |
| 11/10/2025 | BMO | ROIV | Roivant Sciences | Q2 2026 | EPS | -0.33 | -0.28 | 15.15 | -0.25 | -12.00 | |
| 11/10/2025 | BMO | ROIV | Roivant Sciences | Q2 2026 | REV | 6.95 M | 1.57 M | -77.39 | 4.48 M | -64.89 | |
| 08/11/2025 | BMO | ROIV | Roivant Sciences | Q1 2026 | EPS | -0.30 | -0.25 | 16.67 | -0.17 | -47.10 | |
| 08/11/2025 | BMO | ROIV | Roivant Sciences | Q1 2026 | REV | 7.70 M | 2.17 M | -71.80 | 55.13 M | -96.06 |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 04/16/2026 | ROIV | Piper Sandler | Overweight | Overweight | Maintain |
| 03/04/2026 | ROIV | HC Wainwright & Co. | Buy | Buy | Maintain |
| 02/10/2026 | ROIV | Citigroup | Buy | Buy | Maintain |
| 02/10/2026 | ROIV | HC Wainwright & Co. | Buy | Buy | Maintain |
| 02/09/2026 | ROIV | Guggenheim | Buy | Buy | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|
Sign-Up to see the full list of CATALYSTS in the Calendars